Literature DB >> 3114551

[Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia].

N Niederle, C Doberauer, O Kloke, K Höffken, C G Schmidt.   

Abstract

Six patients with hairy-cell leukemia were treated with gamma-(IFN-gamma) and alpha-(IFN-alpha-2b) interferon; 3-35 months following splenectomy, treatment was started with 4 X 10(6) U/m2 IFN-gamma sc (iv) every second day for 9-35 weeks. Although the white blood cell counts decreased during therapy from 4.1-49 X 10(9)/l to 1.5-43 X 10(9)/l, no hematological or clinical improvement was obtained. Subsequently (interval 0-13 weeks), IFN-alpha-2b was given at an initial dose of 4 X 10(6) U/m2 sc every second day to all patients. After a treatment period corresponding to that of IFN-gamma administration, a significant hematological improvement was observed in five patients (one early death due to pulmonary embolism). At the last follow-up (9-14 months after start of treatment; maintenance therapy, 1 X 10(6) U every second day), these patients exhibited normal peripheral blood cell counts, and in bone marrow biopsy specimens a marked decrease of hairy cells was seen (1 CR, 3 PR, 1 MR). Adverse reactions including fever, headache, nausea, dryness of the mouth, myalgia, and fatigue did not significantly differ between the two interferon preparations. Whereas IFN-gamma is unlikely to have any significant impact on the course of hairy cell leukemia, IFN-alpha-2b does result in improvement of hematological values and well-being in almost all patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3114551     DOI: 10.1007/bf01875510

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  41 in total

Review 1.  [The interferon system with special reference to gamma-interferons].

Authors:  H Kirchner
Journal:  Dtsch Med Wochenschr       Date:  1986-01-10       Impact factor: 0.628

2.  Bone marrow biopsy with unaltered architecture: a new biopsy device.

Authors:  K Jamshidi; W R Swaim
Journal:  J Lab Clin Med       Date:  1971-02

3.  [Effect of interferon-alpha 2 (E. coli) in hairy cell leukemia].

Authors:  V Hofmann; A Scheel; J Schwarzmeier; I Talstad; M Varini; S Kaplan; C Sauter; J Fehr
Journal:  Schweiz Med Wochenschr       Date:  1985-02-16

4.  Production of immune interferon by murine T-cell clones from long-term cultures.

Authors:  F Marcucci; M Waller; H Kirchner; P Krammer
Journal:  Nature       Date:  1981-05-07       Impact factor: 49.962

5.  Hairy cell leukemia: clinical presentation and follow-up of 211 patients.

Authors:  G Flandrin; F Sigaux; G Sebahoun; P Bouffette
Journal:  Semin Oncol       Date:  1984-12       Impact factor: 4.929

6.  Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells.

Authors:  R Devos; H Cheroutre; Y Taya; W Degrave; H Van Heuverswyn; W Fiers
Journal:  Nucleic Acids Res       Date:  1982-04-24       Impact factor: 16.971

7.  B cell growth factor-induced proliferation of hairy cell lymphocytes and inhibition by type I interferon in vitro.

Authors:  K A Paganelli; S S Evans; T Han; H Ozer
Journal:  Blood       Date:  1986-04       Impact factor: 22.113

8.  Structure of the human immune interferon gene.

Authors:  P W Gray; D V Goeddel
Journal:  Nature       Date:  1982-08-26       Impact factor: 49.962

9.  Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.

Authors:  S Carrel; A Schmidt-Kessen; L Giuffrè
Journal:  Eur J Immunol       Date:  1985-02       Impact factor: 5.532

10.  The effects of alpha and gamma interferons on human lung cancer cells grown in vitro or as xenografts in nude mice.

Authors:  P R Twentyman; P Workman; K A Wright; N M Bleehen
Journal:  Br J Cancer       Date:  1985-07       Impact factor: 7.640

View more
  2 in total

1.  [Therapeutic procedure in hairy cell leukemia].

Authors:  P von Wussow
Journal:  Klin Wochenschr       Date:  1987-07-15

2.  [Beta interferon therapy in hairy cell leukemia].

Authors:  P von Wussow; J Dühlmann; T Grethlein; W D Hirschmann; E Hügl; O Koch; W R Martin; H W Pees; W Urbanitz; M Freund
Journal:  Klin Wochenschr       Date:  1987-07-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.